Copy to clipboard 
TA Associates, through EM Intressenter AB, hereby announces a public offer to the shareholders of Elos Medtech to tender all their shares to EM Intressenter at a price of SEK 215 in cash per share. The Offer includes shares of both series A and B in the Company. The shares of series B in Elos Medtech are listed on Nasdaq Stockholm, Small Cap.
The acceptance period for the Offer is expected to commence on or about 14 June 2021 and expire on or about 5 July 2021.
Lovisa Lander, Principal at TA Associates, said,
“Having followed Elos Medtech’s development over several years, we have been impressed by the Company and its management team. However, in order to achieve the long-term potential of the business, we believe that significant investments are required, and with our knowledge, network and resources, we believe TA Associates can help the Company with its continued growth journey. We believe that the Offer represents an attractive valuation to shareholders, fully reflecting Elos Medtech’s challenges and opportunities. We look forward to working together with the management team to support Elos Medtech as it continues to strengthen its position as a high-quality development and manufacturing partner with a MedTech focus.”
Elos Medtech is a development and production partner for orthopedic implants, instruments and components with a global presence in Europe, Asia and North America.
